glp-1 course GLP-1: Weight Loss Support Training GLP-1R and Diabetes
Description
In our laboratory, we investigated the protective effect of geniposide (GLP-1RA) in dexamethasone-induced osteogenic inhibition

Factors like weight loss, stress, or dietary changes could also contribute

Blood was collected into tubes containing 1.25 mg EDTA and aprotinin (500 kallikrein-inhibiting units/ml blood) (Wako Pure Chemical Industries), and all samples were centrifuged within 2 h of collection
These decisions should be made in consultation with your GP or diabetes team

In practice, if a therapy is considered, success should be defined with measurable endpointssleep quality, function, waist circumference/body composition (when appropriate), and metabolic markersrather than vague claims alone

In the SMART trial, Semaglutide 2.4 mg reduced albuminuria in people with overweight or obesity and CKD without diabetes with 52% reduction in UACR
